BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 11723064)

  • 1. PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance.
    Guerre-Millo M; Rouault C; Poulain P; André J; Poitout V; Peters JM; Gonzalez FJ; Fruchart JC; Reach G; Staels B
    Diabetes; 2001 Dec; 50(12):2809-14. PubMed ID: 11723064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-alpha deficiency does not alter insulin sensitivity in mice maintained on regular or high-fat diet: hyperinsulinemic-euglycemic clamp studies.
    Haluzik M; Gavrilova O; LeRoith D
    Endocrinology; 2004 Apr; 145(4):1662-7. PubMed ID: 14670996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased glucose tolerance in N-type Ca2+ channel alpha(1B)-subunit gene-deficient mice.
    Takahashi E; Ito M; Miyamoto N; Nagasu T; Ino M; Tanaka I
    Int J Mol Med; 2005 Jun; 15(6):937-44. PubMed ID: 15870896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective modification of pyruvate dehydrogenase kinase isoform expression in rat pancreatic islets elicited by starvation and activation of peroxisome proliferator-activated receptor-alpha: implications for glucose-stimulated insulin secretion.
    Sugden MC; Bulmer K; Augustine D; Holness MJ
    Diabetes; 2001 Dec; 50(12):2729-36. PubMed ID: 11723055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-alpha deficiency protects aged mice from insulin resistance induced by high-fat diet.
    Cha DR; Han JY; Su DM; Zhang Y; Fan X; Breyer MD; Guan Y
    Am J Nephrol; 2007; 27(5):479-82. PubMed ID: 17652964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased insulin secretion and normalization of glucose tolerance by cholinergic agonism in high fat-fed mice.
    Ahrén B; Sauerberg P; Thomsen C
    Am J Physiol; 1999 Jul; 277(1):E93-102. PubMed ID: 10409132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production.
    Xu J; Xiao G; Trujillo C; Chang V; Blanco L; Joseph SB; Bassilian S; Saad MF; Tontonoz P; Lee WN; Kurland IJ
    J Biol Chem; 2002 Dec; 277(52):50237-44. PubMed ID: 12176975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute (24 h) activation of peroxisome proliferator-activated receptor-alpha (PPARalpha) reverses high-fat feeding-induced insulin hypersecretion in vivo and in perifused pancreatic islets.
    Holness MJ; Smith ND; Greenwood GK; Sugden MC
    J Endocrinol; 2003 May; 177(2):197-205. PubMed ID: 12740007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation.
    Ye JM; Doyle PJ; Iglesias MA; Watson DG; Cooney GJ; Kraegen EW
    Diabetes; 2001 Feb; 50(2):411-7. PubMed ID: 11272155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice.
    Ahrén B; Simonsson E; Scheurink AJ; Mulder H; Myrsén U; Sundler F
    Metabolism; 1997 Jan; 46(1):97-106. PubMed ID: 9005977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of peroxisome proliferator-activated receptor-alpha in the modulation of glucose-stimulated insulin secretion.
    Sugden MC; Holness MJ
    Diabetes; 2004 Feb; 53 Suppl 1():S71-81. PubMed ID: 14749269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets.
    Lalloyer F; Vandewalle B; Percevault F; Torpier G; Kerr-Conte J; Oosterveer M; Paumelle R; Fruchart JC; Kuipers F; Pattou F; Fiévet C; Staels B
    Diabetes; 2006 Jun; 55(6):1605-13. PubMed ID: 16731822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma-deficient mice on a high-fat diet.
    Matsui J; Terauchi Y; Kubota N; Takamoto I; Eto K; Yamashita T; Komeda K; Yamauchi T; Kamon J; Kita S; Noda M; Kadowaki T
    Diabetes; 2004 Nov; 53(11):2844-54. PubMed ID: 15504964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency.
    Miles PD; Barak Y; He W; Evans RM; Olefsky JM
    J Clin Invest; 2000 Feb; 105(3):287-92. PubMed ID: 10675354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet.
    Nunemaker CS; Chen M; Pei H; Kimble SD; Keller SR; Carter JD; Yang Z; Smith KM; Wu R; Bevard MH; Garmey JC; Nadler JL
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1065-75. PubMed ID: 18780776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinin B1 receptor deficiency protects mice fed by cafeteria diet from abnormal glucose homeostasis.
    Correia PE; Gomes CB; Bandeira VA; Marten T; Natividade GR; Merello P; Tozawa E; Cerski CTS; Budu A; Araújo R; Arbo BD; Ribeiro MFM; Barros CC; Gerchman F
    PLoS One; 2022; 17(5):e0267845. PubMed ID: 35617279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered beta-cell distribution of pdx-1 and GLUT-2 after a short-term challenge with a high-fat diet in C57BL/6J mice.
    Reimer MK; Ahrén B
    Diabetes; 2002 Feb; 51 Suppl 1():S138-43. PubMed ID: 11815473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic islet response to hyperglycemia is dependent on peroxisome proliferator-activated receptor alpha (PPARalpha).
    Bihan H; Rouault C; Reach G; Poitout V; Staels B; Guerre-Millo M
    FEBS Lett; 2005 Apr; 579(11):2284-8. PubMed ID: 15848159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity.
    Watson E; Hahm S; Mizuno TM; Windsor J; Montgomery C; Scherer PE; Mobbs CV; Salton SR
    Endocrinology; 2005 Dec; 146(12):5151-63. PubMed ID: 16141392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of G protein-coupled receptor 39 impairs insulin secretion in vivo.
    Tremblay F; Richard AM; Will S; Syed J; Stedman N; Perreault M; Gimeno RE
    Endocrinology; 2009 Jun; 150(6):2586-95. PubMed ID: 19213841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.